Accelerating Commercialisation
The status, timeline and source of this project. A free account opens every field.
Source: GrantConnect
Biosensis has developed a novel, ultra–sensitive enzyme–linked immunosorbent assay (ELISA) for use by medical researchers in universities and industry. These novel kits will allow potential tools for detection and measurement of diseases previously not possible due to lack of sensitivity in tests. Accelerating Commercialisation support will be used to help Biosensis commercialise these state–of–t
- Status
- Prospective
- Sector
- Education, Hospital, Government
- Location
- Australia
- Updated
- 19 Nov 2026
- Source
- GrantConnect
ConstructChat
Ask ConstructChat about Accelerating Commercialisation
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | grant award |
Taiyo status | Prospective |
Taiyo last update | 2026-11-19 |
Contact
| Not available for this record. |
Description
Description | Biosensis has developed a novel, ultra–sensitive enzyme–linked immunosorbent assay (ELISA) for use by medical researchers in universities and industry. These novel kits will allow potential tools for detection and measurement of diseases previously not possible due to lack of sensitivity in tests. Accelerating Commercialisation support will be used to help Biosensis commercialise these state–of–the–art ELISA kits and achieve significant export sales, while assisting in the diagnosis and treatment of diseases that have poor or non–existent treatment options. |
Original sector | Business Development |
Budget |
Location
Country | Australia |
Source
Source | GrantConnect |
URL |
More Details
Record type | Project |
Sector | Education, Hospital, Government |
Article published date | 2024-12-16 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
